Development of a hypoxia-responsive vector for tumor-specific gene therapy

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Gene Therapy

• Publication date

  2000-03-01

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1038/sj.gt.3301124PMID 10757022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue oxygen distribution in head and neck cancer patients

  1999cited by this paper
• Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes.

  1998cited by this paper
• Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability.

  1998cited by this paper
• In Vivo Gene Therapy for Prostate Cancer: Preclinical Evaluation of Two Different Enzyme-Directed Prodrug Therapy Systems Delivered by Identical Adenovirus Vectors

  1998cited by this paper
• The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

  1998cited by this paper
• Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.

  1997cited by this paper
• In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma.

  1997cited by this paper
• Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment

  1997cited by this paper
• Targeting gene expression to hypoxic tumor cells

  1997cited by this paper
• Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck.

  1997cited by this paper
• Sequencing of the human vascular endothelial growth factor (VEGF) 3' untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites.

  1997cited by this paper
• Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression.

  1996cited by this paper
• Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1*

  1996cited by this paper
• Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

  1996cited by this paper
• The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy.

  1996cited by this paper
• Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia (*)

  1996cited by this paper
• Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia.

  1996cited by this paper
• Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

  1996cited by this paper
• Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension.

  1996cited by this paper
• Transcriptional activation by tetracyclines in mammalian cells.

  1995cited by this paper
• Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer.

  1995cited by this paper
• Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability

  1995cited by this paper
• Gene therapy for cancer using tumour-specific prodrug activation.

  1994cited by this paper
• Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin.

  1994cited by this paper
• Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.

  1994cited by this paper
• Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

  1993cited by this paper
• SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.

  1993cited by this paper
• A 24-base-pair sequence 3' to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer.

  1993cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

  1992cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper
• Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.

  1991cited by this paper
• The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways.

  1989cited by this paper
• Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences

  1988cited by this paper
• The regulated expression of erythropoietin by two human hepatoma cell lines.

  1987cited by this paper
• A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

  1986cited by this paper
• Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

  1986cited by this paper
• A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.

  1985cited by this paper

• Envirotune-CAR-T: a hypoxia-responsive and glutamine-enhanced CAR-T cell therapy for overcoming tumor microenvironment-mediated suppression

  2025cites this paper
• Engineering stimuli-responsive nanocarriers for CRISPR/Cas9 genome editing: next-generation cancer therapeutics.

  2025cites this paper
• Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells.

  2025cites this paper
• In Vitro Sonodynamic Therapy Using a High Throughput 3D Glioblastoma Spheroid Model with 5‐ALA and TMZ Sonosensitizers

  2024cites this paper
• Genetically Encoded Reporters to Monitor Hypoxia.

  2024cites this paper
• Synthetic Promoters in Gene Therapy: Design Approaches, Features and Applications

  2024cites this paper
• Systemic Delivery of Magnetogene Nanoparticle Vector for Gene Expression in Hypoxic Tumors

  2023cites this paper
• The therapeutic effect of PEI-Fe3O4/pYr-ads-8-5HRE-cfosp-IFNG albumin nanospheres combined with magnetic fluid hyperthermia on hepatoma

  2023cites this paper
• Targeted RASSF1A expression inhibits proliferation of HER2‑positive breast cancer cells in vitro.

  2023cites this paper
• Hypoxia-responsive CAR-T cells exhibit reduced exhaustion and enhanced efficacy in solid tumors.

  2023cites this paper
• Liposomes Under Shear: Structure, Dynamics, and Drug Delivery Applications

  2023cites this paper
• Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles

  2022cites this paper
• Gene Therapy in Orthopaedics: Progress and Challenges in Pre-Clinical Development and Translation

  2022cites this paper
• Hypoxia responsive phytonanotheranostics: A novel paradigm towards fighting cancer.

  2022cites this paper
• High throughput screen for the improvement of inducible promoters for tumor microenvironment cues

  2022cites this paper
• Nanotherapy for Brain Tumor Drug Delivery

  2021cites this paper
• Cell line development for continuous high cell density biomanufacturing: Exploiting hypoxia for improved productivity

  2021influential citation
• Molecular and Functional Imaging and Theranostics of the Tumor Microenvironment

  2021cites this paper
• Hypoxia-directed tumor targeting of CRISPR/Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles

  2021cites this paper
• In vivo noninvasive preclinical tumor hypoxia imaging methods: a review

  2021cites this paper
• Title: Hypoxia-directed tumor targeting of CRISPR/Cas9 and HSV-TK

  2021cites this paper
• Toward gene therapy in rheumatoid arthritis

  2020cites this paper
• Genetic analysis of potential regulators of HIF-1 in C. elegans

  2020cites this paper
• Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines

  2020cites this paper
• Genetically Encoded Tools for Research of Cell Signaling and Metabolism under Brain Hypoxia

  2020influential citation
• Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells

  2020cites this paper
• Reversal of Hypoxic Pulmonary Hypertension by Hypoxia-Inducible Overexpression of Angiotensin-(1-7) in Pulmonary Endothelial Cells

  2020cites this paper
• Towards gene therapy for rheumatoid arthritis

  2020cites this paper
• Insights into Hypoxia: Non-invasive Assessment through Imaging Modalities and Its Application in Breast Cancer

  2019cites this paper
• Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis.

  2019cites this paper
• Molecular and functional imaging insights into the role of hypoxia in cancer aggression

  2019cites this paper
• 4-O-Methylascochlorin inhibits the prolyl hydroxylation of hypoxia-inducible factor-1α, which is attenuated by ascorbate

  2019cites this paper
• Physical stimuli-responsive vesicles in drug delivery: Beyond liposomes and polymersomes.

  2019cites this paper
• Generation of a hypoxia‐sensing mouse model

  2019cites this paper
• Hypoxia-Induced Reporter Genes with Different Half-Lives.

  2018cites this paper
• The hypoxic tumor microenvironment in vivo selects tumor cells with increased survival against genotoxic stresses.

  2018cites this paper
• Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives.

  2018cites this paper
• Constructing a Novel Hypoxia-Inducible Bidirectional shRNA Expression Vector for Simultaneous Gene Silencing in Colorectal Cancer Gene Therapy

  2018cites this paper
• The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells

  2018influential citation
• Graphene oxide–hydroxyapatite nanocomposites effectively deliver HSV-TK suicide gene to inhibit human breast cancer growth

  2018cites this paper
• Gene delivery of hypoxia-inducible VEGF targeting collagen effectively improves cardiac function after myocardial infarction

  2017cites this paper
• A Novel Hypoxia Imaging Endoscopy System

  2017cites this paper
• Context-dependent intravital imaging of therapeutic response using intramolecular FRET biosensors.

  2017cites this paper
• Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy

  2017cites this paper
• Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo

  2017cites this paper
• A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells

  2017cites this paper
• Involvement of c‐Jun N‐Terminal Kinase in TNF‐&agr;‐Driven Remodeling

  2017cites this paper
• Mitochondrial deficiency impairs hypoxic induction of HIF-1 transcriptional activity and retards tumor growth

  2017cites this paper
• 10 Hypoxia Responsive Vectors Targeting Astrocytes in Glioma

  2017cites this paper
• Exploiting the cancer niche: Tumor‐associated macrophages and hypoxia as promising synergistic targets for nano‐based therapy

  2017influential citation
• Direct visualization of the phenotype of hypoxic tumor cells at single cell resolution in vivo using a new hypoxia probe

  2016cites this paper
• Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application

  2016cites this paper
• Hypoxia: A Double-Edged Sword in Cancer Therapy

  2016influential citation
• Study of the combined treatment of lung cancer using gene-loaded immunomagnetic albumin nanospheres in vitro and in vivo

  2016cites this paper
• Hypoxia-Sensitive Materials for Biomedical Applications

  2016cites this paper
• A combination hepatoma-targeted therapy based on nanotechnology: pHRE-Egr1-HSV-TK/131I-antiAFPMcAb-GCV/MFH

  2016cites this paper
• Contribution of MicroRNAs to autoimmune diseases

  2016cites this paper
• A novel injectable BRET-based in vivo imaging probe for detecting the activity of hypoxia-inducible factor regulated by the ubiquitin-proteasome system

  2016cites this paper
• PMEPA1, a TGF-β- and hypoxia-inducible gene that participates in hypoxic gene expression networks in solid tumors.

  2016influential citation
• Quantitative Analyses of Core Promoters Enable Precise Engineering of Regulated Gene Expression in Mammalian Cells.

  2016cites this paper
• Influential Factors and Synergies for Radiation-Gene Therapy on Cancer

  2015cites this paper
• TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α.

  2015cites this paper
• Blood–brain barrier pathophysiology in brain tumors

  2015cites this paper
• Targeted Gene Therapy for Ischemic Stroke

  2015cites this paper
• Monitoring nutrient transport in tissue‐engineered grafts

  2015cites this paper
• Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivo

  2015cites this paper
• Infection by Cx43 adenovirus increased chemotherapy sensitivity in human gastric cancer BGC-823 cells: not involving in induction of cell apoptosis.

  2015cites this paper
• Gene Delivery and Therapy for Neurological Disorders

  2015cites this paper
• A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level

  2015cites this paper
• VEGF transfer based on gene-modified fibroblasts using a hypoxia-induced vector to modulate neoangiogenesis in ischaemic regions of myocutaneous transplants.

  2015cites this paper
• Cigarette Smoke Extract Induces a Phenotypic Shift in Epithelial Cells; Involvement of HIF1α in Mesenchymal Transition

  2014influential citation
• Hypoxia differentially regulates muscle oxidative fiber type and metabolism in a HIF-1α-dependent manner.

  2014cites this paper
• Diabetes Irreversibly Depletes Bone Marrow–Derived Mesenchymal Progenitor Cell Subpopulations

  2014cites this paper
• Tracking Cell Fate with Synthetic Memory and Pulse Detecting Transcriptional Circuits

  2014cites this paper
• Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor

  2014cites this paper
• In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay

  2014cites this paper
• Detailed assessment of gene activation levels by multiple hypoxia-responsive elements under various hypoxic conditions

  2014cites this paper
• Prevention of hypoxic pulmonary hypertension by hypoxia-inducible expression of p27 in pulmonary artery smooth muscle cells

  2014cites this paper
• In vivo imaging of hypoxia-inducible factor regulation in a subcutaneous and orthotopic GL261 glioma tumor model using a reporter gene assay.

  2014cites this paper
• Combinatorial Control of Transgene Expression by Hypoxia-Responsive Promoter and MicroRNA Regulation for Neural Stem Cell-Based Cancer Therapy

  2014cites this paper
• stabilization in human cancer cells Anoxic induction of ATF-4 via HIF-1 independent pathways of protein

  2013cites this paper
• The role of co-activating factors in the HIF-mediated hypoxia response

  2013cites this paper
• Characterizing Hypoxia and Its Behavioral Effects In 3-Dimensional Cell Aggregates

  2013cites this paper
• pH-responsive and charge shielded cationic micelle of poly(L-histidine)-block-short branched PEI for acidic cancer treatment.

  2013cites this paper
• Hypoxia as a target for tissue specific gene therapy.

  2013cites this paper
• Regulated expression systems for gene therapy

  2013cites this paper
• Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling

  2013cites this paper
• Influence of the Tumor Microenvironment on Genomic Changes Conferring Chemoresistance in Breast Cancer

  2013cites this paper
• Angiogenesis in Brain Tumors

  2013cites this paper
• Hypoxia Responsive Vectors Targeting Astrocytes in Glioma

  2012cites this paper
• Synthetic memory circuits for tracking human cell fate.

  2012influential citation
• Neuroprotection of neurotrophin-3 against focal cerebral ischemia/reperfusion injury is regulated by hypoxia-responsive element in rats.

  2012cites this paper
• Thermoacoustic Imaging and Spectroscopy for Enhanced Cancer Diagnostics

  2012cites this paper
• Hypoxia-regulated neurotrophin-3 expression by multicopy hypoxia response elements reduces apoptosis in PC12 cells.

  2012cites this paper
• Molecular Imaging with Activatable Reporter Systems

  2012cites this paper
• Inhibition of hypoxia-inducible transcription factor complex with designed epipolythiodiketopiperazine.

  2011cites this paper
• A protein therapeutic modality founded on molecular regulation

  2011cites this paper
• An evaluation on transfection efficiency of pHRE-Egr1-EGFP in hepatocellular carcinoma cells Bel-7402 mediated by PEI-MZF-NPs

  2011cites this paper
• Intraoperative fluorescence imaging in cancer

  2011cites this paper
• Tumor Hypoxia Imaging

  2011cites this paper